Literature DB >> 9302201

Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients.

T F Ismail1, M O Wasfy, B A Oyofo, M M Mansour, H M El-Berry, A M Churilla, S S Eldin, L F Peruski.   

Abstract

Serum and stool samples were collected from 128 individuals: 96 diarrhea patients and 32 apparently healthy controls. Stool specimens were cultured for enteric bacterial pathogens, while sera were screened by enzyme-linked immunosorbent assay for Campylobacter jejuni-reactive antibodies. Of 28 diarrhea patients who demonstrated C. jejuni-reactive antibodies (titers, > 100), 14 were culture positive for this organism. The 32 healthy controls showed significantly lower antibody titers (P < 0.05) with the exception of 10 subjects who were culture positive for C. jejuni and had reactive immunoglobulin M (IgM) (6 subjects) and IgG (7 subjects). IgA was not detected in those 10 individuals (asymptomatic). Avidity was expressed as the thiocyanate ion concentration required to inhibit 50% of the bound antibodies. The avidity was higher in symptomatic patients than asymptomatic healthy controls. IgG was less avid (0.92 M) compared to IgM (0.1 M) and IgA (1.1 M), with no correlation between antibody titer and avidity. However, the thiocyanate ion concentration required for the complete inhibition of IgG (5 M)-bound antibodies was higher than that of IgA (2 M) and IgM (3 M). This study also shows that C. jejuni antibodies were variably cross-reactive with Escherichia coli, Shigella flexneri, Shigella sonnei, and Neisseria meningitidis in addition to Campylobacter coli and Campylobacter rectus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302201      PMCID: PMC170589          DOI: 10.1128/cdli.4.5.536-539.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  25 in total

1.  Evaluation of the quantity and affinity of human IgG "blocking" antibodies.

Authors:  N F Adkinson; A K Sobotka; L M Lichtenstein
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

2.  Antibody affinity and valence in viral neutralization.

Authors:  S E Blank; G A Leslie; L W Clem
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

3.  The relationship between antibody affinity and the efficiency of complement fixation.

Authors:  A S Fauci; M M Frank; J S Johnson
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

4.  Avidity in immunoadsorption of IgG antibodies.

Authors:  D E Lopatin; E W Voss
Journal:  Immunochemistry       Date:  1974-07

5.  Effect of immunoglobulin class and affinity on the initiation of complement-dependent damage to liposomal model membranes sensitized with dinitrophenylated phospholipids.

Authors:  H R Six; K I Uemura; S C Kinsky
Journal:  Biochemistry       Date:  1973-09-25       Impact factor: 3.162

6.  Differences in immune elimination in inbred mice. The role of low affinity antibody.

Authors:  J H Alpers; M W Steward; J F Soothill
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

7.  Symptomatic mumps virus reinfections.

Authors:  J P Gut; C Lablache; S Behr; A Kirn
Journal:  J Med Virol       Date:  1995-01       Impact factor: 2.327

Review 8.  Campylobacter enteritis.

Authors:  M J Blaser; L B Reller
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

9.  Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients.

Authors:  E Lutz; K N Ward; J J Gray
Journal:  J Med Virol       Date:  1994-12       Impact factor: 2.327

10.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

View more
  2 in total

1.  Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.

Authors:  M A Strid; J Engberg; L B Larsen; K Begtrup; K Mølbak; K A Krogfelt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection.

Authors:  K H Chan; K Sonnenberg; M Niedrig; S Y Lam; C M Pang; K M Chan; S K Ma; W H Seto; J S M Peiris
Journal:  Clin Vaccine Immunol       Date:  2007-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.